The Senior Director will lead the global launch of INZ-701, an enzyme replacement therapy designed to restore pyrophosphate and adenosine levels. This role demands a strategic thinker with a proven track record of successfully bringing rare disease pharmaceutical products to the market, coupled with the ability to navigate the complexities of global regulatory & reimbursement environments.
Requirements
- Degree in life sciences, business administration, or a related field.
Requirements: 10+ years of experience in pharmaceutical or biotechnology industry with a proven track record of leading global product launches